IASLC Early Detection and Screening Committee to Report on global obstacles to lung cancer scree...
Recorded Sunday, August 7th @ WCLC 2022 in Vienna, Austria
Видео IASLC Early Detection and Screening Committee to Report on global obstacles to lung cancer scree... канала Oncoletter
Видео IASLC Early Detection and Screening Committee to Report on global obstacles to lung cancer scree... канала Oncoletter
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Adjuvante endokrine Therapie bei prä- und postmenopausalen Patientinnen J. Huober, U. Nitz](https://i.ytimg.com/vi/mj_EQ-ZwExE/default.jpg)
![ASCO Annual Meeting 2022 - Press Conference - Monday, June 6](https://i.ytimg.com/vi/vSzns4o8CJk/default.jpg)
![Interview with Prof. Dr. med. Reinhard Dummer, Zürich - COBRIM-study](https://i.ytimg.com/vi/TXLykauIOPE/default.jpg)
![Dr. med. A. Müller: To the Bone: Wie ist das nun mit Prolia, Aclasta und Zometa?](https://i.ytimg.com/vi/Tjn6Mxe1ryY/default.jpg)
![The Issue of Steroid Use with Immune Checkpoint Inhibition: Alessandra Curioni](https://i.ytimg.com/vi/2IUGqzcD3I4/default.jpg)
![ASCO23 - LBA4: SWOG S1826, Nivolumab(N)-AVD vs. Brentuximab Vedotin(BV)-AVD in Advanced Stage (A...](https://i.ytimg.com/vi/d1jn1-q9QYQ/default.jpg)
![Prof. Dr. med. Mathias Warm](https://i.ytimg.com/vi/2JlALZ2GEwE/default.jpg)
![F. Honecker: Herausforderungen bei der Behandlung geriatrischer Patienten](https://i.ytimg.com/vi/QBnbks5h2vI/default.jpg)
![SABCS2020: Highlights beim triple negativen Mammakarzinom](https://i.ytimg.com/vi/iWLHNiFBpX4/default.jpg)
![Session 7: Extent of surgery post neoadjuvant – setting: Estimating the extent of surgery (Flori...](https://i.ytimg.com/vi/q0avjC9yBZw/default.jpg)
![ASCO23 - LBA1: INDIGO: Vorasidenib versus placebo in patients with residual or recurrent grade 2...](https://i.ytimg.com/vi/nwzEb4iLTpc/default.jpg)
![SABCS 2022: Prof. Dr. med. Wolfgang Janni, Ulm Stellenwert von ctDNA](https://i.ytimg.com/vi/PjTNEX8_hRw/default.jpg)
![FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell](https://i.ytimg.com/vi/yz5ttntL6QY/default.jpg)
![Evaluation of TMB in KEYNOTE-189: Pembrolizumab + CT vs Placebo + CT for Nonsquamous NSCLC](https://i.ytimg.com/vi/qtaQLhIanX8/default.jpg)
![Discussion of tissue engineered bronchus](https://i.ytimg.com/vi/yYnSdqqHjAA/default.jpg)
![Prof. Volkmar Müller, Renate Haidinger, Brustkrebs Deutschland e.v., Prof. Christian Jackisch: K...](https://i.ytimg.com/vi/8-MRl97fvpc/default.jpg)
![#ASCO21 - Oleg Gluz: WSG-ADAPT HR+/HER2- Ergebnisse in der Hochrisikogruppe](https://i.ytimg.com/vi/fRgo9pQRXgA/default.jpg)
![Strahlentherapie der Brust – Ist weniger mehr?](https://i.ytimg.com/vi/2ZwbIDYK7Ko/default.jpg)
![Dr. med. S. Riniker: Endokrine Therapie: Tradition und Moderne](https://i.ytimg.com/vi/L3aCnWXQxlM/default.jpg)
![Summary of most important changes AGO breast cancer guidelines 2021](https://i.ytimg.com/vi/SE6j8rgrBhM/default.jpg)
![ASCO 2015: Die Highlights zum Brustkrebs von Experten diskutiert](https://i.ytimg.com/vi/jLBMTYTMyfc/default.jpg)